Scientific publications

Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis

Subirá D, Serrano C, Castañón S, Gonzalo R, Illán J, Pardo J, Martínez-García M, Millastre E, Aparisi F, Navarro M, Dómine M, Gil-Bazo I, Pérez Segura P, Gil M, Bruna J.
Department of Hematology, Hospital de Guadalajara,Guadalajara, Spain (D.S.); Department of Hematology, Fundación Jiménez Díaz, Madrid, Spain (C.S., S.C., R.G.); Unilabs Diagnósticos, SLU, Madrid, Spain (J.I.); Department of Neurology, Hospital Quirón Madrid, Pozuelo de Alarcón, Madrid, Spain (J.P.); Department of Oncology, Hospital del Mar, Barcelona, Spain (M.M-G.); Department of Oncology, Hospital Miguel Servet, Zaragoza, Spain (E.M.); Department of Oncology, Hospital Virgen de los Lirios, Alcoy, Spain (F.A.); Department of Oncology, Hospital Universitario de Salamanca, Salamanca, Spain (M.N.); Department of Oncology, Fundación Jiménez Díaz, Madrid, Spain (M.D.); Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain (I.G-B.); Department of Oncology, Hospital Clínico San Carlos, Madrid, Spain (P.P.S.); Unit of Neuro-Oncology, Departments of Oncology and Neurology, Universidad Hospital de Bellvitge-ICO Duran i Reynals, Hospitalet de Llobregat, Spain (M.G., J.B.).

Magazine: Neuro-Oncology

Date: Oct 12, 2011

Medical Oncology

Purpose
To explore the contribution of flow cytometry immunophenotyping (FCI) in detecting leptomeningeal disease in patients with solid tumors.

Experimental design
Cerebrospinal fluid (CSF) samples from 78 patients who received a diagnosis of epithelial-cell solid tumors and had clinical data suggestive of leptomeningeal carcinomatosis (LC) were studied. A novel FCI protocol was used to identify cells expressing the epithelial cell antigen EpCAM and their DNA content. Accompanying inflammatory cells were also described. FCI results (positive or negative for malignancy) were compared with those from CSF cytology and with the diagnosis established by the clinicians: patients with LC (n = 49), without LC (n = 26), and undetermined (n = 3).

Results
FCI described a wide range of EpCAM-positive cells with a hyperdiploid DNA content in the CSF of patients with LC. Compared with cytology, FCI showed higher sensitivity (75.5 vs 65.3) and negative predictive value (67.6 vs 60.5), and similar specificity (96.1 vs 100) and positive predictive value (97.4 vs 100). Concordance between cytology and FCI was high (Kp = 0.83), although misdiagnosis of LC did not show differences between evaluating the CSF with 1 or 2 techniques (P = .06).

Receiver-operator characteristic curve analyses showed that lymphocytes and monocytes had a different distribution between patients with and without LC.

Conclusion
FCI seems to be a promising new tool for improving the diagnostic examination of patients with suspicion of LC. Detection of epithelial cells with a higher DNA content is highly specific of LC, but evaluation of the nonepithelial cell compartment of the CSF might also be useful for supporting this diagnosis.

CITATION  Neuro Oncol. 2011 Oct 12

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra